1) elevation in SCr
血肌酐升高
2) Serum creatinine
血清肌酐
1.
SCysC and serum creatinine(Scr)were determined before surgery,1 week and 4 weeks after surgery,respectively.
方法采用颗粒增强透射免疫比浊法(PETIA)分别检测39例初次肾移植患者在术前、术后1周和4周的SCysC水平,并与血清肌酐(Scr)、内生肌酐清除率(Ccr)进行比较分析。
2.
Serum creatinine(Scr)was measured by enzymic method.
5 mL保存,测血清肌酐作为基线资料。
3.
Objective: To evaluate the applicability of serum cystatin C ,serum creatinine and urine microprotein as endogenous marker for detection of renal disfunction in patients with chronic kidney disease.
目的探讨血清半胱氨酸蛋白酶抑制剂C (Cystatin C )、血清肌酐(Scr)及尿微量蛋白(α1-MG、ALB、TRF)在评价慢性肾脏病患者肾功能损害中的比较及血清CysC浓度判定在肾小球滤过功能中的临床价值。
3) Scr
血肌酐
1.
Methods:The 198 patients with chronic renal failure,according to the Guideline to clinical research of Chinese traditional medicine and new drug,will operate TCM differentiation typing while the level of serum ET,BUN,SCr and CCr were measured.
目的:研究慢性肾功能衰竭(CRF)患者中医证型在CRF四期(代偿期、失代偿期、衰竭期、尿毒症期)的分布规律以及不同中医证型中尿素氮(BUN)、血肌酐(SCr)、内生肌酐清除率(CCr)、血浆内皮素(ET)的水平变化。
4) Serum creatinine
血肌酐
1.
Effects of calcium dobesilate on serum creatinine;
羟本磺酸钙降低血肌酐机制的研究
2.
Objective To evaluate creatinine clearance rate(Ccr) revised by body surface area(BSA) in the patients with nephropathy,we observed the difference between Ccr and revised Ccr by BSA,and compared them with serum creatinine and cystatin C.
目的评价经体表面积校正后的肾病患者肌酐清除率(creatin ine c learance rate,Ccr)的临床意义,并观察Ccr实测值与Ccr校正值之间的差异及其两者与血肌酐及cystatin C的相关性分析。
5) Blood creatinine
血肌酐
1.
Qbserve the urine quantity, blood creatinine and urine NAG, urine RBP Results The urine quantity, blood creatinine , urine NAG and urine RBP is no predominance difference between treatment group and comparison group ( P>0.
观察尿量、血肌酐及尿NAG、尿视黄醇结合蛋白变化。
6) plasma creatinine
血浆肌酐
1.
Effects of human tissue kallikrein gene A1789G polymorphism on plasma creatinine levels in patients with essential hypertension;
组织激肽释放酶基因多态性A1789G对高血压患者血浆肌酐水平的影响(英文)
2.
Objective To set up reference intervals of plasma creatinine in clinical laboratory.
目的通过测定广州市健康成年人群的肝素锂抗凝血浆肌酐值,建立该实验室血浆肌酐的生物参考区间。
补充资料：肌氨基酐
分子式：C4H7N3O
分子量：113.12
CAS号：60-27-5
性质：白色结晶。热至300℃分解，溶于水，微溶于醇，几乎不溶于醚、丙酮和氯仿。
制备方法：将900g水合肌酸、550ml浓盐酸和150ml水加热24h。热滤，滤液在冰浴中冷至0-5℃，加入1L28%氨水。冷却下搅拌，使温度降至0℃，滤出肌酐晶体，用氨水洗涤至不含氯离子，再用冷甲醇洗涤，干燥，得肌酐约550g。
用途：分析试剂（血液鉴定）、生化研究试剂。
分子量：113.12
CAS号：60-27-5
性质：白色结晶。热至300℃分解，溶于水，微溶于醇，几乎不溶于醚、丙酮和氯仿。
制备方法：将900g水合肌酸、550ml浓盐酸和150ml水加热24h。热滤，滤液在冰浴中冷至0-5℃，加入1L28%氨水。冷却下搅拌，使温度降至0℃，滤出肌酐晶体，用氨水洗涤至不含氯离子，再用冷甲醇洗涤，干燥，得肌酐约550g。
用途：分析试剂（血液鉴定）、生化研究试剂。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条